COST UTILITY ANALYSIS OF ONCE-WEEKLY SEMAGLUTIDE AND DULAGLUTIDE FOR PATIENTS WITH TYPE 2 DIABETES IN SAUDI ARABIA

被引：0
|
作者：
Hassan, M. [1 ]
Barham, L. [2 ]
机构：
[1] Novo Nordisk, Riyadh 01, Saudi Arabia
[2] Univ South Wales, Learna Ltd Partnership, Royston, Hrt, England
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE23
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of once-weekly semaglutide low dose 0.5 mg vs once-weekly dulaglutide high dose 1.5 mg in type 2 diabetes: a post hoc analysis of SUSTAIN 7
    Pratley, R. E.
    Aroda, V. R.
    Gondolf, T.
    Hansen, T.
    Lingvay, I.
    Ludemann, J.
    Skjoth, T. V.
    Viljoen, A.
    DIABETOLOGIA, 2019, 62 : S374 - S374
  • [32] Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis
    Kristin Cecilie Carlsson Petri
    Steen Hvass Ingwersen
    Anne Flint
    Jeppe Zacho
    Rune Viig Overgaard
    Diabetes Therapy, 2018, 9 : 1533 - 1547
  • [33] Baseline factors associated with glycaemic response to treatment with once-weekly dulaglutide in patients with type 2 diabetes
    Wysham, Carol
    Guerci, Bruno
    D'Alessio, David
    Jia, Nan
    Botros, Fady T.
    DIABETES OBESITY & METABOLISM, 2016, 18 (11): : 1138 - 1142
  • [34] COST-EFFECTIVENESS ANALYSIS OF ONCE-WEEKLY SEMAGLUTIDE VERSUS POLYETHYLENE GLYCOL LOXENATIDE FOR TREATMENT OF TYPE 2 DIABETES IN CHINA
    Liu, L.
    Zhen, R.
    Ung, C. O. L.
    Shen, Y.
    Zhang, Y.
    Han, S.
    Jia, R.
    Qiao, J.
    Hu, H.
    Guo, L.
    VALUE IN HEALTH, 2022, 25 (12) : S116 - S116
  • [35] Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands (vol 7, e000705, 2019)
    Hunt, B.
    Malkin, S. J. P.
    Moes, R. G. J.
    BMJ OPEN DIABETES RESEARCH & CARE, 2019, 7 (01)
  • [36] A POPULATION-ADJUSTED INDIRECT COMPARISON OF CARDIOVASCULAR BENEFITS BETWEEN ONCE-WEEKLY SEMAGLUTIDE AND DULAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES AND HIGH CARDIOVASCULAR RISK
    Evans, L. M.
    Mellbin, L.
    Johansen, P.
    Lawson, J.
    Paine, A.
    Sandberg, A.
    VALUE IN HEALTH, 2020, 23 : S110 - S110
  • [37] Incorporating Cardioprotective Effects of Once-Weekly Semaglutide in Estimates of Health Benefits for Patients with Type 2 Diabetes
    Evans, Marc
    Johansen, Pierre
    Vrazic, Hrvoje
    DIABETES, 2018, 67
  • [38] The effects of once-weekly semaglutide on beta cell function in subjects with type 2 diabetes
    Kapitza, C.
    Dahl, K.
    Jacobsen, J. Bonde
    Axelsen, M. Buhl
    Flint, A.
    DIABETOLOGIA, 2016, 59 : S358 - S359
  • [39] A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release, Dulaglutide and Liraglutide in the UK
    Pierre Johansen
    Anna Sandberg
    Matthew Capehorn
    Advances in Therapy, 2020, 37 : 1248 - 1259
  • [40] A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release, Dulaglutide and Liraglutide in the UK
    Johansen, Pierre
    Sandberg, Anna
    Capehorn, Matthew
    ADVANCES IN THERAPY, 2020, 37 (03) : 1248 - 1259
12345